Press Releases June 29, 2026 06:34 PM

FEMSA Schedules Conference Call to Discuss Second Quarter Financial Results

FEMSA announces Q2 2026 earnings conference call scheduled for July 28

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
FMX

FEMSA, a leading company in retail and beverage sectors with substantial operations in Mexico, Latin America, Europe, and the United States, has scheduled a conference call on July 28, 2026, to discuss its second quarter financial results. The company operates major retail outlets including OXXO stores and is the largest franchise bottler of Coca-Cola products globally by volume through its beverage arm, Coca-Cola FEMSA.

FEMSA Schedules Conference Call to Discuss Second Quarter Financial Results
FMX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • FEMSA operates in retail and beverage sectors across multiple regions including the US, Latin America, and Europe.
  • The company runs multiple retail divisions, including OXXO convenience stores and digital financial services via the Spin platform.
  • FEMSA is a significant player in the Coca-Cola bottling business worldwide and is listed on the NYSE as FMX.
  • The Q2 earnings release and conference call are scheduled for July 28, 2026, with public access via Zoom and replay available on the investor relations website.

MONTERREY, Mexico, June 29, 2026 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) is pleased to invite you to participate in its Second Quarter Conference Call that will be held on:

Tuesday, July 28, 2026
11:00 AM Eastern Time
(9:00 AM Mexico City Time)

To participate in the conference call please register at the following link:

Registration: FEMSA Conference Call | 2Q26

The quarterly results will be released on July 28 before markets open.

The conference call will be live through our Zoom link. For registration, please visit https://bit.ly/FEMSA_2Q26

If you are unable to participate live, the conference call replay will be available on http://ir.femsa.com/results.cfm

About FEMSA
FEMSA is a company that creates economic and social value through companies and institutions and strives to be the best employer and neighbor to the communities in which it operates. It participates in two core sectors, retail and beverages. In retail, FEMSA is present through four divisions: i) OXXO Mexico, operating the largest small-format store chain in Mexico; ii) Americas & Mobility, which includes its OXXO convenience store operations across Latin America and the United States, as well as its gas station business in Mexico and the United States; iii) FEMSA Europe, operating convenience and foodvenience formats in five European countries; and iv) FEMSA Health, which includes drugstores and related activities in four Latin American countries. In Mexico, OXXO’s operations are enhanced by, and comprise a customer-focused ecosystem with Spin, a digital platform that leverages the OXXO store network to provide Mexican consumers with access to digital financial services, including Spin by OXXO and Spin Premia, among other initiatives. In the beverage sector, FEMSA participates through Coca-Cola FEMSA, the largest franchise bottler of Coca-Cola products in the world by volume. Across its business units, FEMSA has more than 369,000 employees in 18 countries. FEMSA is a member of the Dow Jones Best-in-Class World Index & Dow Jones Best-in-Class MILA Pacific Alliance Index, both from S&P Global; FTSE4Good Emerging Index; MSCI EM Latin America ESG Leaders Index; S&P/BMV Total México ESG, among other indexes.


Risks

  • Uncertainties inherent in retail operations across diverse geographic markets could impact financial results.
  • Exposure to the beverage market and dependencies on Coca-Cola product sales could affect performance depending on consumer demand fluctuations.
  • Risks related to regulatory, economic, and currency variations in multiple operating countries including the US, Mexico, and European markets.

More from Press Releases

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2 Jun 29, 2026 Plum Acquisition Corp. IV Announces Postponement of Extraordinary General Meeting of Shareholders Jun 29, 2026 OceanFirst Financial Corp. Completes Previously Announced Sale of $1.3 Billion of New York City Multifamily Loans Jun 29, 2026 FTI Consulting Strengthens Mining Capabilities in Australia With Appointment of Dean Felton Jun 29, 2026 OpenPayd Announces Filing of Registration Statement on Form F-4 in Connection with its Proposed Business Combination with Titan Acquisition Corp. (Nasdaq: TACH). Jun 29, 2026